FOLD Q2 2019 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$44M+107.1% YoY

Gross Profit

$39M87.8% margin

Operating Income

-$76M-173.2% margin

Net Income

-$85M-191.6% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

+29.6%

Cash Flow

Operating Cash Flow

-$58M

Free Cash Flow

-$61M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$918M

Total Liabilities

$318M

Stockholders' Equity

$600M

Cash & Equivalents

$221M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$21M	+107.1%
Gross Profit	$39M	$18M	+113.3%
Operating Income	-$76M	-$47M	-62.9%
Net Income	-$85M	-$62M	-36.7%

Geographic Segments

Non-US

$32M72%

UNITED STATES

$12M28%